NASDAQ:PETS - Petmed Express Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$28.71 -1.93 (-6.30 %)
(As of 10/24/2018 01:09 AM ET)
Previous Close$30.64
Today's Range$28.44 - $30.07
52-Week Range$27.63 - $57.80
Volume1.55 million shs
Average Volume657,344 shs
Market Capitalization$578.99 million
P/E Ratio15.77
Dividend Yield3.86%
Beta0.55
PetMed Express, Inc. and its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. It markets prescription and non-prescription pet medications, and other health products for dogs and cats directly to the consumers. The company offers non-prescription medications and supplies, including flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, such as heartworm preventative, flea and tick preventative, arthritis, thyroid, diabetes, pain, heart/blood pressure, and other specialty medications, as well as generic substitutes. It also sells food, beds, crates, stairs, strollers, and other pet supplies. The company sells its products through its Internet Website; telephone contact center; and direct mail/print through brochures and postcards. PetMed Express, Inc. was founded in 1996 and is headquartered in Delray Beach, Florida.

Receive PETS News and Ratings via Email

Sign-up to receive the latest news and ratings for PETS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Drug stores & proprietary stores
Sub-IndustryInternet Retail
SectorRetail/Wholesale
Current SymbolNASDAQ:PETS
Previous Symbol
CUSIP71638210
Phone561-526-4444

Debt

Debt-to-Equity RatioN/A
Current Ratio4.41
Quick Ratio3.52

Price-To-Earnings

Trailing P/E Ratio15.77
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$273.80 million
Price / Sales2.17
Cash Flow$1.9624 per share
Price / Cash14.63
Book Value$5.62 per share
Price / Book5.11

Profitability

EPS (Most Recent Fiscal Year)$1.82
Net Income$37.28 million
Net Margins14.42%
Return on Equity35.77%
Return on Assets29.63%

Miscellaneous

Employees187
Outstanding Shares20,690,000
Market Cap$578.99 million
OptionableN/A

Petmed Express (NASDAQ:PETS) Frequently Asked Questions

What is Petmed Express' stock symbol?

Petmed Express trades on the NASDAQ under the ticker symbol "PETS."

How often does Petmed Express pay dividends? What is the dividend yield for Petmed Express?

Petmed Express declared a quarterly dividend on Tuesday, October 23rd. Investors of record on Monday, November 5th will be given a dividend of $0.27 per share on Friday, November 16th. This represents a $1.08 annualized dividend and a dividend yield of 3.76%. The ex-dividend date is Friday, November 2nd. View Petmed Express' Dividend History.

How were Petmed Express' earnings last quarter?

Petmed Express Inc (NASDAQ:PETS) issued its earnings results on Monday, October, 22nd. The company reported $0.52 earnings per share for the quarter, beating the consensus estimate of $0.50 by $0.02. The firm earned $71.40 million during the quarter, compared to analyst estimates of $71.93 million. Petmed Express had a net margin of 14.42% and a return on equity of 35.77%. Petmed Express's quarterly revenue was up 7.0% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.43 earnings per share. View Petmed Express' Earnings History.

When is Petmed Express' next earnings date?

Petmed Express is scheduled to release their next quarterly earnings announcement on Monday, January 28th 2019. View Earnings Estimates for Petmed Express.

What price target have analysts set for PETS?

4 analysts have issued twelve-month price objectives for Petmed Express' stock. Their predictions range from $32.00 to $58.00. On average, they anticipate Petmed Express' share price to reach $45.00 in the next twelve months. This suggests a possible upside of 56.7% from the stock's current price. View Analyst Price Targets for Petmed Express.

What is the consensus analysts' recommendation for Petmed Express?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Petmed Express in the last year. There are currently 1 sell rating, 2 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Petmed Express.

Who are some of Petmed Express' key competitors?

Who are Petmed Express' key executives?

Petmed Express' management team includes the folowing people:
  • Mr. Menderes Akdag, CEO, Pres & Director (Age 57)
  • Mr. Bruce S. Rosenbloom, CFO & Treasurer (Age 49)
  • Ms. Alison Berges, Corp. Sec. & Gen. Counsel

Who are Petmed Express' major shareholders?

Petmed Express' stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Menlo Advisors LLC (0.47%), Personal Capital Advisors Corp (0.44%), Scout Investments Inc. (0.40%), North Star Investment Management Corp. (0.37%) and Aurora Investment Counsel (0.22%). Company insiders that own Petmed Express stock include Bruce S Rosenbloom, Frank J Formica, Gian Fulgoni, Menderes Akdag, Robert C Schweitzer and Ronald J Korn. View Institutional Ownership Trends for Petmed Express.

Which institutional investors are selling Petmed Express stock?

PETS stock was sold by a variety of institutional investors in the last quarter, including North Star Investment Management Corp. and Personal Capital Advisors Corp. Company insiders that have sold Petmed Express company stock in the last year include Frank J Formica, Gian Fulgoni, Menderes Akdag, Robert C Schweitzer and Ronald J Korn. View Insider Buying and Selling for Petmed Express.

Which institutional investors are buying Petmed Express stock?

PETS stock was purchased by a variety of institutional investors in the last quarter, including Menlo Advisors LLC, Aurora Investment Counsel and Scout Investments Inc.. View Insider Buying and Selling for Petmed Express.

How do I buy shares of Petmed Express?

Shares of PETS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Petmed Express' stock price today?

One share of PETS stock can currently be purchased for approximately $28.71.

How big of a company is Petmed Express?

Petmed Express has a market capitalization of $578.99 million and generates $273.80 million in revenue each year. The company earns $37.28 million in net income (profit) each year or $1.82 on an earnings per share basis. Petmed Express employs 187 workers across the globe.

What is Petmed Express' official website?

The official website for Petmed Express is http://www.1800petmeds.com.

How can I contact Petmed Express?

Petmed Express' mailing address is 420 SOUTH CONGRESS AVENUE, DELRAY BEACH FL, 33445. The company can be reached via phone at 561-526-4444.


MarketBeat Community Rating for Petmed Express (NASDAQ PETS)

Community Ranking:  1.5 out of 5 (star half star)
Outperform Votes:  132 (Vote Outperform)
Underperform Votes:  302 (Vote Underperform)
Total Votes:  434
MarketBeat's community ratings are surveys of what our community members think about Petmed Express and other stocks. Vote "Outperform" if you believe PETS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PETS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/24/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel